Episode #29: Three Breakthroughs: Exciting News on Alzheimer’s, Warming Globe Problems and Solutions, and Smart Antibiotics
Tech Optimist Podcast — Tech, Entrepreneurship, and Innovation
Dive into a captivating episode of the Alumni Ventures’ Tech Optimist podcast as Mike Collins and Matt Caspari explore three breakthroughs that could redefine our health and environment. They kick off the discussion with the promising FDA approval of a new Alzheimer’s drug, offering hope in slowing the progression of this debilitating disease. Next, they tackle the pressing issue of global warming, discussing the record-breaking heat of summer 2023 and innovative solutions to combat climate change. The episode concludes with a look at a revolutionary smart antibiotic that promises efficacy without compromising the microbiome, potentially transforming medical treatments. Join Mike and Matt as they delve into these technological advancements that hold the potential to improve our world dramatically.
Episode #29 – Three Breakthroughs
See video policy below.
This week on the Tech Optimist podcast, join Alumni Ventures’ Mike Collins and Matt Caspari as they cover three exciting breakthroughs:
- New Alzheimer’s Drug: Discover the hope brought by the FDA’s approval of a drug designed to slow the progression of Alzheimer’s disease.
- Climate Change Solutions: Delve into the challenges of global warming, including the record-breaking heat of summer 2023, and explore innovative solutions to combat climate change.
- Revolutionary Smart Antibiotic: Learn about a new antibiotic that promises efficacy without compromising the microbiome, potentially transforming medical treatments.
Don’t miss this insightful discussion on technological advancements that could significantly enhance our world
Tune in to discover how these innovations are shaping the future.
Watch Time ~30 minutes
The show is produced by Alumni Ventures, which has been recognized as a “Top 20 Venture Firm” by CB Insights (’24) and as the “#1 Most Active Venture Firm in the US” by Pitchbook (’22 & ’23).
READ THE FULL EPISODE TRANSCRIPT
Creators and Guests
HOST
Mike Collins
CEO, and Co-Founder at Alumni Ventures
Mike has been involved in almost every facet of venturing, from angel investing to venture capital, new business and product launches, and innovation consulting. He is currently CEO of Alumni Ventures Group, the managing company for our fund, and launched AV’s first alumni fund, Green D Ventures, where he oversaw the portfolio as Managing Partner and is now Managing Partner Emeritus. Mike is a serial entrepreneur who has started multiple companies, including Kid Galaxy, Big Idea Group (partially owned by WPP), and RDM. He began his career at VC firm TA Associates. He holds an undergraduate degree in Engineering Science from Dartmouth and an MBA from Harvard Business School.
GUEST
Matt Caspari
Managing Partner, Alumni Ventures
Matt Caspari is a Managing Partner at Alumni Ventures, where he leads the Deep Tech, Georgetown (Potomac Ventures) and UC Berkeley (Strawberry Creek Ventures) funds. He invests in mission-driven founders developing groundbreaking technologies. His investments encompass a diverse range of sectors, including AI, agriculture, aviation, battery technology, cybersecurity, direct air capture of CO2, energy generation, longevity, and robotics.
To Learn More
Click the logos below for more information.
Important Disclosure Information
The Tech Optimist Podcast is for informational purposes only. It is not personalized advice and is neither an offer to sell, nor a solicitation of an offer to purchase, any security. Such offers are made only to eligible investors, pursuant to the formal offering documents of appropriate investment funds. Please consult with your advisors before making any investment with Alumni Ventures. For more information, please see here.
One or more investment funds affiliated with AV may have invested, or may in the future invest, in some of the companies featured on the Podcast. This circumstance constitutes a conflict of interest. Any testimonials or endorsements regarding AV on the Podcast are made without compensation but the providers may in some cases have a relationship with AV from which they benefit. All views expressed on the Podcast are the speaker’s own. Any testimonials or endorsements expressed on the Podcast do not represent the experience of all investors or companies with which AV invests or does business.
The Podcast includes forward-looking statements, generally consisting of any statement pertaining to any issue other than historical fact, including without limitation predictions, financial projections, the anticipated results of the execution of any plan or strategy, the expectation or belief of the speaker, or other events or circumstances to exist in the future. Forward looking statements are not representations of actual fact, depend on certain assumptions that may not be realized, and are not guaranteed to occur. Any forward- looking statements included in this communication speak only as of the date of the communication. AV and its affiliates disclaim any obligation to update, amend, or alter such forward-looking statements whether due to subsequent events, new information, or otherwise.